Tibet Research Development from 2010 to 2025
| TBET Stock | USD 0.0001 0.00 0.00% |
Research Development | First Reported 2010-12-31 | Previous Quarter 710.7 K | Current Value 676.5 K | Quarterly Volatility 26.8 K |
Check Tibet Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tibet Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 2.5 M or Total Revenue of 26 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 488.7 K or PTB Ratio of 0.0. Tibet financial statements analysis is a perfect complement when working with Tibet Pharmaceuticals Valuation or Volatility modules.
Tibet | Research Development | Build AI portfolio with Tibet Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Tibet Stock Analysis
When running Tibet Pharmaceuticals' price analysis, check to measure Tibet Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tibet Pharmaceuticals is operating at the current time. Most of Tibet Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tibet Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tibet Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tibet Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.